Driven both by surging demand and rapid technology advancements, an emerging area of health innovation called “bioconvergence” is driving improvements in human health and sustained interest from investors. This episode will explore these new applications merging engineered technologies with scientific disciplines, including in diagnostics, therapeutics, and elsewhere.

Nobel Laureate Dr. Jim Rothman, Dr. Melanie Mathieu of Prellis Biologics, and Daniel Dornbusch of Excision join host Michael Marks for an in-depth discussion covering advancements in CRISPR technology, the role of AI in drug discovery, the future of personalized medicine, and much more.

Legendary technology founder and venture capital investor Vinod Khosla joins host Michael Marks for a wide-ranging discussion on the future of Artificial Intelligence, major tech cycles, and much more. Vinod shares his predictions for the next 25 years of technology advancement and how we should be assessing the risks and benefits as the adoption of AI continues to accelerate. He shares his views on founder friendly and why "hypocritical politeness" is so common in Silicon Valley. Vinod co-founded Sun Microsystems and helped create several technology companies before founding Khosla Ventures in 2004. The firm has since invested in countless game-changing technology companies including OpenAI, Doordash, Impossible Foods, Rubrik, and others.  

The TechSurge Podcast explores topics at the intersection of emerging tech, market forces, and entrepreneurial discovery. Hear directly from Silicon Valley leaders, the next generation of daring founders, and other brilliant minds shaping the future of deep tech. Episodes releasing every two weeks.